The OECD report highlighted a rapid rise in oncology drug approvals, from four medicines annually between 2004-2011 to 17 and 15 medicines in 2021 and 2022, respectively. 1 Despite this, inequalities ...

Wondering where to invest your money in the new year? There are many options to choose from: high-yield savings accounts, CDs, bonds, funds, stocks and gold, just to name a few. The best investment ...

U.S. stocks have delivered strong returns for more than a decade, but a growing body of valuation data suggests the market may be running too hot. One widely cited gauge is the cyclically adjusted ...